
“This Is Personal”: Do Your Part to Help Reduce Deaths From Colon Cancer
In July1999, I learned I was pregnant with my son. My sister was pregnant, too, and due to deliver in the fall. I was excited to share my happy news. But my father, then 65, had news of his own: he had been diagnosed with stage III colorectal cancer.
In July 1999, I learned I was pregnant with my son. My sister was pregnant, too, and due to deliver in the fall. I was excited to share my happy news. But my father, then 65, had news of his own: he had been diagnosed with
My dad was depressed. He blamed his cancer on long-ago junk-food indulgences, including one summer when he “ate ice cream for lunch every day.” His tumor responded well to neoadjuvant chemoradiation, though, and after surgical resection, he had a temporary ileostomy. He’s a proud survivor and still receives newsletters from Memorial Sloan-Kettering Cancer Center, where he was treated.
My mother’s father had had colon cancer, too. He died in 1976 at age 70, a few months after diagnosis. My grandfather and my father exemplify some of the important changes that have taken place in the field of colon cancer treatment and prevention over the past several decades.
Certainly,
For instance, colonoscopy and the stool guaiac test were just introduced in the late 1960s. Video-guided endoscopies did not come into use until the late 1970s. Cisplatin was approved in 1971, the year that President Nixon declared a “war on cancer” in his State of the Union Address and asked for
Contrast this with a cancer-management milestone from around the time my father was being treated: in 2001, initial findings from the Human Genome Project were made available, along with advanced DNA sequencing technologies that continue to shed light on clinically important genomic changes in certain cancers. In 2008 at ASCO, for example, practice-changing research showed colorectal cancer patients with KRAS gene mutations do not respond to the EGRF inhibitor cetuximab (Erbitux), leading ASCO to issue a Provisional Clinical Opinion in January 2009
On the screening front, in 2010, a large randomized controlled trial of 170,000 + people in the UK showed one-time screening of men and women 55–64 years old with flexible sigmoidoscopy
Virtual colonoscopies
And in the March 2011 issue of the Journal of the American College of Radiology, a study analyzing American Hospital Association survey data reported that
Clearly, screening is vital to colorectal cancer prevention, and to better outcomes when malignancies are found. Improvements in screening-and increased efforts by advocacy groups and celebrities to educate the public about its importance-have
The CDC provides excellent resources as part of its “
Because my sister and I are at higher risk for colorectal cancer,
March is
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.